Effect of clopidogrel besylate on platelet reactivity in patients with acute coronary syndromes. Comparison with clopidogrel hydrogen sulfate

Clopidogrel differentially affects platelet-mediated thrombosis and inflammatory response in patients with acute coronary syndromes

(2011) K. I. KALANTZI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Proton pump inhibitors, genetic polymorphisms and response to clopidogrel therapy

(2011) Himawan Fernando et al.   THROMBOSIS AND HAEMOSTASIS

Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

(2010) Laurent Bonello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiovascular Death and Nonfatal Myocardial Infarction in Acute Coronary Syndrome Patients Receiving Coronary Stenting Are Predicted by Residual Platelet Reactivity to ADP Detected by a Point-of-Care Assay

(2009) Rossella Marcucci et al.   CIRCULATION

Comparing the antiplatelet effect of clopidogrel hydrogensulfate and clopidogrel besylate: a crossover study

(2009) Horst Neubauer et al.   Clinical Research in Cardiology

Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: A randomized, open-label, crossover study in healthy Korean male subjects

(2009) Sung-Doo Kim et al.   CLINICAL THERAPEUTICS

Which platelet function test is suitable to monitor clopidogrel responsiveness? A pharmacokinetic analysis on the active metabolite of clopidogrel

(2009) H. J. BOUMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients

(2009) J. B. Muhlestein   THROMBOSIS AND HAEMOSTASIS

A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study

(2009) Tullio Palmerini et al.   THROMBOSIS RESEARCH

Platelets: Inflammatory Firebugs of Vascular Walls

(2008) Andreas E. May et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention

(2008) Boris Aleil et al.   JACC-Cardiovascular Interventions

Adjusted Clopidogrel Loading Doses According to Vasodilator-Stimulated Phosphoprotein Phosphorylation Index Decrease Rate of Major Adverse Cardiovascular Events in Patients With Clopidogrel Resistance

(2008) Laurent Bonello et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY